...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Halted

Apparently it's a third party data vendor that has confused the two companies. So the incorrect info goes out to the brokerages, financial websites, etc.  Last year I emailed the compliance departments at the two brokerage I use and got them to fix their web sites.  It's likely to be an ongoing problem until the data vendor fixes their confusion.

Share
New Message
Please login to post a reply